These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15315924)

  • 41. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical antipsychotics in the treatment of delirium.
    Peritogiannis V; Stefanou E; Lixouriotis C; Gkogkos C; Rizos DV
    Psychiatry Clin Neurosci; 2009 Oct; 63(5):623-31. PubMed ID: 19674385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of centrally acting cholinesterase inhibitor exposures in adults.
    McCain KR; Sawyer TS; Spiller HA
    Ann Pharmacother; 2007 Oct; 41(10):1632-7. PubMed ID: 17848422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug treatment of delirium: past, present and future.
    Bourne RS; Tahir TA; Borthwick M; Sampson EL
    J Psychosom Res; 2008 Sep; 65(3):273-82. PubMed ID: 18707951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can postoperative delirium be prevented pharmacologically?
    Fong JJ; Devlin JW
    Crit Care Med; 2009 May; 37(5):1825-6. PubMed ID: 19373065
    [No Abstract]   [Full Text] [Related]  

  • 46. Rivastigmine patches: line extension. No therapeutic advantage and less convenient than capsules.
    Prescrire Int; 2009 Feb; 18(99):19. PubMed ID: 19391277
    [No Abstract]   [Full Text] [Related]  

  • 47. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rivastigmine in the treatment of postoperative delirium: a pilot clinical trial.
    Zaslavsky A; Haile M; Kline R; Iospa A; Frempong-Boadu A; Bekker A
    Int J Geriatr Psychiatry; 2012 Sep; 27(9):986-8. PubMed ID: 22886871
    [No Abstract]   [Full Text] [Related]  

  • 50. [A new approach to the treatment of delirium: atypical antipsychotics].
    Onur E; Cimilli C
    Turk Psikiyatri Derg; 2005; 16(3):216-24. PubMed ID: 16180154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.
    Lefèvre G; Sedek G; Jhee SS; Leibowitz MT; Huang HL; Enz A; Maton S; Ereshefsky L; Pommier F; Schmidli H; Appel-Dingemanse S
    Clin Pharmacol Ther; 2008 Jan; 83(1):106-14. PubMed ID: 17522596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rivastigmine reduces tobacco craving in alcohol-dependent smokers.
    Diehl A; Nakovics H; Mutschler J; Hermann D; Kiefer F
    Pharmacopsychiatry; 2009 May; 42(3):89-94. PubMed ID: 19452376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients.
    Rea RS; Battistone S; Fong JJ; Devlin JW
    Pharmacotherapy; 2007 Apr; 27(4):588-94. PubMed ID: 17381385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholinesterase inhibitor treatment in patients with delirium.
    Opdam FL; Oleksik AM; Westendorp RG
    Lancet; 2011 Mar; 377(9769):900-1; author reply 901. PubMed ID: 21397759
    [No Abstract]   [Full Text] [Related]  

  • 55. [A comparative study of the effectiveness and tolerability of a procedure involving slow dose-escalation of rivastigmine in patients with mild or moderate Alzheimer-type dementia: the SCALEX study].
    Agüera-Ortiz LF; Ramos-García M; Gobartt AL;
    Rev Neurol; 2008 May 1-15; 46(9):517-24. PubMed ID: 18446692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rivastigmine: new indication. Dementia and Parkinson's disease: no thank you!
    Prescrire Int; 2007 Apr; 16(88):66. PubMed ID: 17458048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.
    Frankfort SV; Appels BA; De Boer A; Tulner LR; Van Campen JP; Koks CH; Beijnen JH
    Int J Clin Pract; 2006 Jun; 60(6):646-54. PubMed ID: 16805746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholinesterase inhibitor treatment in patients with delirium.
    de Pont AC; van Geer MA; Schultz MJ
    Lancet; 2011 Mar; 377(9769):899; author reply 901. PubMed ID: 21397757
    [No Abstract]   [Full Text] [Related]  

  • 59. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients.
    Kim JY; Jung IK; Han C; Cho SH; Kim L; Kim SH; Lee BH; Lee HJ; Kim YK
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):183-8. PubMed ID: 15823165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
    Mahlberg R; Walther S; Eichmann U; Tracik F; Kunz D
    Arch Gerontol Geriatr; 2007; 45(1):19-26. PubMed ID: 16963137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.